Search research articles
Contact Us
Filters
Showing results (181-190 of 946) with videos related to
Page
of 95
Sort By:
JACC. Advances
|
January 1, 2026
Long-Term Cardiovascular Health Trajectories Associated With Cardiovascular Disease and Mortality in Older Adults
Yi Li, Yunqing Han, Yuanming Leng, et al.
Internal Medicine Journal
|
December 2, 2017
Barriers to medication adherence and links to cardiovascular disease risk factor control: the Framingham Heart Study
Rachel Hennein, Shih-Jen Hwang, Rhoda Au, et al.
The American Journal of Cardiology
|
April 26, 2003
Doppler transmitral flow indexes and risk of atrial fibrillation (the Framingham Heart Study)
Ramachandran S Vasan, Martin G Larson, Daniel Levy, et al.
Oncotarget
|
December 25, 2015
The significance of Brf1 overexpression in human hepatocellular carcinoma
Qian Zhong, Shaoyan Xi, Jianzhong Liang, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2002
Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding
Daniel Levy, Charles Marlowe, Kim Kane-Maguire, et al.
Vaccine
|
April 28, 2009
Diphtheria: a zoonotic disease in France?
Isabelle Bonmarin, Nicole Guiso, Anne Le Flèche-Matéos, et al.
Circulation
|
August 13, 2003
Natural history of asymptomatic left ventricular systolic dysfunction in the community
Thomas J Wang, Jane C Evans, Emelia J Benjamin, et al.
Archives of Internal Medicine
|
September 27, 2006
Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control
Nisha I Parikh, Shih-Jen Hwang, Martin G Larson, et al.
Journal of the American Society of Nephrology : JASN
|
June 15, 2013
Elevated galectin-3 precedes the development of CKD
Conall M O'Seaghdha, Shih-Jen Hwang, Jennifer E Ho, et al.
Circulation
|
March 7, 2007
Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals
Thomas J Wang, Martin G Larson, Michelle J Keyes, et al.
Page
of 95
Search research articles
Search
Showing results (181-190 of 946) with videos related to
Sort By:
Page
of 95
JACC. Advances
|
January 1, 2026
Long-Term Cardiovascular Health Trajectories Associated With Cardiovascular Disease and Mortality in Older Adults
Yi Li, Yunqing Han, Yuanming Leng, et al.
Internal Medicine Journal
|
December 2, 2017
Barriers to medication adherence and links to cardiovascular disease risk factor control: the Framingham Heart Study
Rachel Hennein, Shih-Jen Hwang, Rhoda Au, et al.
The American Journal of Cardiology
|
April 26, 2003
Doppler transmitral flow indexes and risk of atrial fibrillation (the Framingham Heart Study)
Ramachandran S Vasan, Martin G Larson, Daniel Levy, et al.
Oncotarget
|
December 25, 2015
The significance of Brf1 overexpression in human hepatocellular carcinoma
Qian Zhong, Shaoyan Xi, Jianzhong Liang, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2002
Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding
Daniel Levy, Charles Marlowe, Kim Kane-Maguire, et al.
Vaccine
|
April 28, 2009
Diphtheria: a zoonotic disease in France?
Isabelle Bonmarin, Nicole Guiso, Anne Le Flèche-Matéos, et al.
Circulation
|
August 13, 2003
Natural history of asymptomatic left ventricular systolic dysfunction in the community
Thomas J Wang, Jane C Evans, Emelia J Benjamin, et al.
Archives of Internal Medicine
|
September 27, 2006
Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control
Nisha I Parikh, Shih-Jen Hwang, Martin G Larson, et al.
Journal of the American Society of Nephrology : JASN
|
June 15, 2013
Elevated galectin-3 precedes the development of CKD
Conall M O'Seaghdha, Shih-Jen Hwang, Jennifer E Ho, et al.
Circulation
|
March 7, 2007
Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals
Thomas J Wang, Martin G Larson, Michelle J Keyes, et al.
Page
of 95